Vol.

No.

March 11, 2016Mar 11, 2016

Free

DOWNLOAD THE PDF

Cover Story

CMS Experiment Targets Incentive to Use the Most Expensive Drug

By Paul Goldberg and Matthew Bin Han Ong

Is Average Sales Price plus 6 percent the right amount to pay doctors under the Medicare Part B program?

Free

Part VII - DePinho's Stock Tip Revisited

By Paul Goldberg

National Academy of Medicine Calls for Integrated FDA-CMS Pathway for Biomarker Tests

By Conor Hale

Companies, Health Systems Commit to Data Interoperability

Study: California Hospitals with Low Volumes of Surgeries Associated with Higher Risks

By Conor Hale

Free Obituary

UNMC Scientist Michael Brattain Dies Unexpectedly at Age 68

In Brief

Esener to Lead Early Detection Research At OHSU Knight Cancer Institute

Jorge Lopez Jr. Named MSKCC General Counsel

Aron Parekh receives research grant from American Cancer Society

Robin Mjelle receives grant from Addario Foundation and International Association for the Study of Lung Cancer

William Grady receives grant from DeGregario Family Foundation and the Price Family Foundation

Baylor College of Medicine and Baylor Scott & White Health enter collaboration

Tufts Medical Center and New England Cancer Specialists form affiliation

UC San Francisco and Berkeley Lights Inc. form collaboration

Drugs & Targets

Xalkori Approved in Metastatic Non-Small Cell Lung Cancer

FDA Approves American College of Radiology Digital Mammography QC Manual

Regulatory Authorities in Six Countries approve Yondelis

China Food and Drug Administration Approves CINtec PLUS Cytology Test

Veritas Genetics introduces whole genome platform for under $1,000

PREVIOUS ISSUE

NEXT ISSUE

Recent Issues